- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.53 No.11
Vol.53 No.11 contents
Presidential Address
Overcoming neurological diseases -breakthrough for new era-
Hidehiro Mizusawa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 893|897, 2013
Educational Lecture 2
Immunology for Understanding the Pathogenesis of Multiple Sclerosis
Makoto Matsui, M.D., Ph.D.1)
CLINICA NEUROL, 53: 898|901, 2013
Educational Lecture 2
Conflict of interest of clinical research in Japan
Saburo Sakoda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 902|902, 2013
Educational Lecture 2
Gene mutations; up date
Masanori Nakagawa, M.D.1)
CLINICA NEUROL, 53: 903|906, 2013
Educational Lecture 2
Essential knowledge of Drugs for Neurologists on Pharmacokinetics and Drug Development in Global Aspects to the World
Masahiro Nomoto, M.D., Ph.D.1), Masahiro Nagai, M.D., Ph.D.1), Noriko Nishikawa, M.D., Ph.D.1), Tomoaki Tsujii, M.D.1) and Hirotaka Iwaki, M.D.1)
CLINICA NEUROL, 53: 907|910, 2013
Educational Lecture 3
Update on deep brain stimulation for movement disorders
Atsushi Umemura, M.D., Ph.D.1), Genko Oyama, M.D., Ph.D.2), Yasushi Shimo, M.D., Ph.D.1)2) and Nobutaka Hattori, M.D., Ph.D.2)
CLINICA NEUROL, 53: 911|914, 2013
Educational Lecture 3
Differential diagnosis and common pathology between Alzheimer's disease and vascular dementia
Hidekazu Tomimoto, M.D., Ph.D.1)
CLINICA NEUROL, 53: 915|918, 2013
Educational Lecture 3
Macroscopic findings of brains are helpful in differential diagnosis of neurological disorders
Mari Yoshida, M.D.1)
CLINICA NEUROL, 53: 919|922, 2013
Educational Lecture 3
Problems with countermeasures of health insurance treatment in neurology
Michiya Ito1)
CLINICA NEUROL, 53: 923|925, 2013
Educational Lecture 3
Neurology in Japan before World War II
Akira Takahashi, M.D.1)
CLINICA NEUROL, 53: 926|929, 2013
Educational Lecture 4
Positron Emission Tomography in Neurological Disorders
Kenji Ishii, M.D.1)
CLINICA NEUROL, 53: 930|930, 2013
Educational Lecture 4
Neurorehabilitation for spinocerebellar degeneration
Ichiro Miyai, M.D., Ph.D.1)
CLINICA NEUROL, 53: 931|933, 2013
Educational Lecture 4
Basic knowledge about Kampo for neurologists
Shin-ichi Muramatsu, M.D., Ph.D.1)
CLINICA NEUROL, 53: 934|937, 2013
Educational Lecture 4
Kampo medicines as useful therapeutic agents in clinical practice of neurology: case reports & representative medicines
Kazuyuki Ishida, M.D., Ph.D.1)
CLINICA NEUROL, 53: 938|941, 2013
Hot Topics 2
MicroRNA in neurodegenerative disorders
Gen Sobue, M.D.1)
CLINICA NEUROL, 53: 942|944, 2013
Hot Topics 2
Epilepsy and higher brain dysfunction
Mitsuru Kawamura, M.D.1) and Azusa Sugimoto, M.D.1)
CLINICA NEUROL, 53: 945|945, 2013
Hot Topics 2
Central Institute for the Molecular Pathomechanisms of Epilepsies
Shinichi Hirose, M.D., Ph.D.1)
CLINICA NEUROL, 53: 946|946, 2013
Hot Topics 3
Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia
Yukiko Hayashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 947|950, 2013
Hot Topics 3
How do the interventional neurologists function in the clinical setting?
Mikito Hayakawa, M.D.1)
CLINICA NEUROL, 53: 951|955, 2013
Hot Topics 3
Alzheimer disease: experimental approaches to genetic and environmental risk factors
Takeshi Iwatsubo, M.D.,1), Tadafumi Hashimoto, Ph.D.,1), Tomoko Wakabayashi, Ph.D.,1), Taisuke Tomita, Ph.D.,2) and Yuichi Morohashi, Ph.D.2)Ph.D.,2) and Yuichi Morohashi, Ph.D.2)
CLINICA NEUROL, 53: 956|956, 2013
Hot Topics 3
The world of functional RNA
Hiromi Okada, Ph.D.1) and Yoshihide Hayashizaki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 957|961, 2013
Hot Topics 3
Brain-machine interface (BMI) - application to neurological disorders
Toshiki Yoshimine, M.D.1), Takufumi Yanagisawa, M.D.1), Masayuki Hirata, M.D.1)
CLINICA NEUROL, 53: 962|965, 2013
Hot Topics 4
Role of Neurosurgical Management in Movement Disorders other than Parkinson Disease
Takaomi Taira, M.D., Ph.D.1)
CLINICA NEUROL, 53: 966|968, 2013
Hot Topics 4
Pathogenesis and treatment of brachial plexus neuritis.
Shu-ichi Ikeda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 969|973, 2013
Symposium 1
Non-motor symptoms in premotor phase of Parkinson disease
Kazushi Takahashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 974|976, 2013
Symposium 1
Initial diagnosis of Parkinson's disease -Neuroradiological diagnosis-
Satoshi Orimo, M.D., Ph.D.1)
CLINICA NEUROL, 53: 977|980, 2013
Symposium 1
Transcranial sobography of substantia nigra in patients with Parkinson's disease
Hideto Miwa, M.D.1)
CLINICA NEUROL, 53: 981|982, 2013
Symposium 1
α-synuclein as biomarker
Kenjiro Ono, M.D., Ph. D.1) and Masahito Yamada, M.D., Ph.D.1)
CLINICA NEUROL, 53: 983|985, 2013
Symposium 1
Thrombus formation and its embolic risk in atrial fibrillation
Hideo Mitamura, M.D., Ph.D.1)
CLINICA NEUROL, 53: 986|988, 2013
Symposium 1
Cardioembolic stroke associated with atrial fibrillation
Kazumi Kimura, M.D., Ph.D.1), Shinji Yamashita, M.D., Ph.D.1) and Kensaku Shibazaki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 989|991, 2013
Symposium 1
Evidence of novel oral anticoagulants (NOAC)
Takanari Kitazono, M.D., Ph.D.1)
CLINICA NEUROL, 53: 992|993, 2013
Symposium 1
How to properly use warfarin and new anticoagulants
Shinichiro Uchiyama, M.D., Ph.D.1)
CLINICA NEUROL, 53: 994|996, 2013
Symposium 1
Prevention and treatment of major bleeding during anticoagulation
Masahiro Yasaka, M.D., Ph.D.1) and Yasushi Okada, M.D., Ph.D.1)
CLINICA NEUROL, 53: 997|999, 2013
Symposium 1
The present state of predictive genetic testing for neuromuscular diseases: An overview by a neurologist in a local hospital
Hiroyuki Ohmori, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1000|1002, 2013
Symposium 1
The present condition and problem of presymptomatic genetic testing
Chieko Kukinaka, R.N., LL.M.1)
CLINICA NEUROL, 53: 1003|1005, 2013
Symposium 1
Current status of predictive genetic testing in neurological diseases
-From the stand point of genetic specialist-
Masayuki Yoshida, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1006|1008, 2013
Symposium 1
Cell replacement therapy for Parkinson's disease using iPS cells
Jun Takahashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1009|1012, 2013
Symposium 1
Current status and perspective on regenerative medicine for spinal cord injury using iPS cell
Masaya Nakamura, M.D., Ph.D.1), Yoshiaki Toyama, M.D., Ph.D.1) and Hideyuki Okano, M.D., Ph.D.2)
CLINICA NEUROL, 53: 1013|1015, 2013
Symposium 1
Retinal cell therapy using iPS cells
Masayo Takahashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1016|1016, 2013
Symposium 1
Stem cell therapy for ischemic stroke using iPS cells
Koichi Oki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1017|1019, 2013
Symposium 1
ALS disease modeling and drug screening using patient-specific iPS cells
Naohiro Egawa, M.D., Ph.D.1)2) and Haruhisa Inoue, M.D., Ph.D.1)2)
CLINICA NEUROL, 53: 1020|1022, 2013
Symposium 1
Clinical aspects of corticobasal syndrome
Takayoshi Shimohata, M.D., Ph.D.1) and Masatoyo Nishizawa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1023|1025, 2013
Symposium 1
The genetic background of corticobasal syndrome
Hiroshi Doi, M.D., Ph.D.1) and Fumiaki Tanaka, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1026|1028, 2013
Symposium 1
Neuroimaging in corticobasal syndrome
Hitoshi Shinotoh, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1029|1032, 2013
Symposium 1
Differential diagnosis of corticobasal syndrome (CBS) and its biomarkers
Takahiko Tokuda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1033|1035, 2013
Symposium 2
The development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions
Shun Shimohama, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1036|1038, 2013
Symposium 2
Current status and perspectives on the development of AD therapeutics based on amyloid cascade hypothesis
Takeshi Iwatsubo, M.D.1)
CLINICA NEUROL, 53: 1039|1039, 2013
Symposium 2
Present and future of the Tau dementia therapy
Akihiko Takashima, Ph.D.1)
CLINICA NEUROL, 53: 1040|1042, 2013
Symposium 2
Oxidative stress hypothesis for Alzheimer's disease and its potential therapeutic implications
Akihiko Nunomura, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1043|1045, 2013
Symposium 2
Update rehabilitation therapy for Parkinson disease
Akito Hayashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1046|1049, 2013
Symposium 2
Repetitive transcranial magnetic stimulation (rTMS) therapy for Parkinson Disease
Yuichiro Shirota, M.D., Ph. D.1)
CLINICA NEUROL, 53: 1050|1052, 2013
Symposium 2
DBS therapy for Parkinson's disease -Our approach-
Sumito Sato, M.D., Ph.D.1), Yoko Takiyama, M.D., Ph.D.2), Yutaka Ogino, M.D., Ph.D.3), Katsushige Watanabe, M.D., Ph.D.4), Tohru Terao, M.D.5), Chihiro Matsumoto, M.D.1), Satomi Chiken, Ph.D.6), Atsushi Nambu, M.D., Ph.D.6), Kazutoshi Nishiyama, M.D., Ph.D.2), Toshihiro Kumabe, M.D., Ph.D.1) and Kiyotaka Fujii, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1053|1055, 2013
Symposium 2
Problem of alternative medicine in Parkinson's disease
Ken-ichi Fujimoto, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1056|1058, 2013
Symposium 2
Autoimmune Encephalitis and its related-disorders
Makoto Yoneda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1059|1062, 2013
Symposium 2
Clinical spectrum of anti-glycine receptor antibody-associated disease
Takahiro Iizuka, M.D.1), Naomi Tominaga, M.D.1) and Juntaro Kaneko, M.D.1)
CLINICA NEUROL, 53: 1063|1066, 2013
Symposium 2
Isaacs's syndrome and associated diseases
Osamu Watanabe, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1067|1070, 2013
Symposium 2
Autoimmune Autonomic Ganglionopathy
Shunya Nakane, M.D.1)2)
CLINICA NEUROL, 53: 1071|1073, 2013
Symposium 2
C9ORF72 in Japanese amyotrophic lateral sclerosis (ALS)
Hiroyuki Tomiyama, M.D., Ph.D1)
CLINICA NEUROL, 53: 1074|1076, 2013
Symposium 2
Molecular pathogenesis of ALS in TDP43 era
Osamu Onodera, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1077|1079, 2013
Symposium 2
Amyotrophic lateral sclerosis (ALS) with the mutations in the fused in sarcoma/translocated in liposarcoma gene
Masashi Aoki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1080|1083, 2013
Symposium 2
Dysfunction of dynactin 1 in motor neuron degeneration
Masahisa Katsuno, M.D., Ph.D.1), Kensuke Ikenaka, M.D., Ph.D.1), Kaori Kawai, Ph.D.1) and Gen Sobue, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1084|1086, 2013
Symposium 2
Cutting-edge MRI techniques for studying neurological diseases focusing on spinocerebellar degeneration
Hirohisa Watanabe, M.D.1), Joe Senda, M.D.1), Mizuki Ito, M.D.1), Naoki Atsuta, M.D.1), Kazuhiro Haram, M.D.1), Hazuki Watanabe1), Ryoichi Nakamura, M.D.1), Takashi Tsuboi, M.D.1), Mari Yoshida, M.D.2), Shinji Naganawa, M.D.3) and Gen Sobue, M.D.1)
CLINICA NEUROL, 53: 1087|1090, 2013
Symposium 2
Principles of voxel-based morphometry and availability of integrated software BAAD
Akihiko Shiino, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1091|1093, 2013
Symposium 2
Cutting-edge of advanced MRI for demyelinating diseases
Masafumi Harada, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1094|1096, 2013
Symposium 2
MRI in Epilepsy and Migraine
Toshihiko Aso, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1097|1099, 2013
Symposium 2
In-vivo analysis for human brain maturation using MRI
Yuji Suzuki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1100|1103, 2013
Symposium 2
α-dystroglycanopathy
Tatsushi Toda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1104|1104, 2013
Symposium 2
Myofibrillar myopaathy
Yukiko Hayashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1105|1108, 2013
Symposium 2
Myotonic dystrophy
Shoichi Ishiura, Ph.D.1), Kosuke Oana, M.S.1) and Michinori Koebis, M.S.1)
CLINICA NEUROL, 53: 1109|1111, 2013
Symposium 2
New congenital muscular dystrophy due to CHKB mutations
Ichizo Nishino, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1112|1113, 2013
Symposium 2
Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies
Jun Shimizu, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1114|1116, 2013
Symposium 2
Immortalized adult rodent Schwann cells as useful tools for the study of peripheral nerve regeneration
Kazunori Sango, M.D., Ph.D.1) and Kazuhiko Watabe, M.D., Ph.D.2)
CLINICA NEUROL, 53: 1117|1119, 2013
Symposium 2
Blood-nerve barrier and peripheral nerve regeneration
Takashi Kanda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1120|1122, 2013
Symposium 2
New horizon of treatments for peripheral nerve disorders
Hitoshi Hirata, M.D., Ph.D.1), Shigeru Kurimoto, M.D., Ph.D.1) and Shuichi Kato, M.D.1)
CLINICA NEUROL, 53: 1123|1123, 2013
Symposium 2
Regenerative medicine of central and peripheral nervous system
Hideyuki Okano, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1124|1124, 2013
Symposium 2
The recent pathophysiology of cluster headache (trigeminal autonomic cephalalgias; TACs)
Tomokazu Shimazu, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1125|1127, 2013
Symposium 2
Clinical profile of cluster headaches in Japan
Noboru Imai, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1128|1130, 2013
Symposium 2
New treatments for cluster headache
Toshihiko Shimizu, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1131|1133, 2013
Symposium 2
Therapeuetic aspects of cluster headache in the practical clinical site
Kiyoshi Owada, M.D.1)
CLINICA NEUROL, 53: 1134|1135, 2013
Symposium 2
International Accreditation of Medical School Towards Quality Assurance of Medical Education
Toshimasa Yoshioka, M.D., Ph.D.1) and Nobuo Nara, M.D., Ph.D.2)
CLINICA NEUROL, 53: 1136|1138, 2013
Symposium 2
An update on postgraduate clinical training
Masahiro Tanabe, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1139|1141, 2013
Symposium 2
Renovation of medical specialty education system in Japan (Current status and future perspectives)
Akira Muraoka, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1142|1144, 2013
Symposium 2
Graduate medical education for neurology in Japan
Masatoyo Nishizawa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1145|1146, 2013
Symposium 2
The current status and problems in neurology education at graduate schools in Japan
Jun-ichi Kira, M.D, Ph.D.1)
CLINICA NEUROL, 53: 1147|1147, 2013
Symposium 3
Earthquake and Neurologists -Role of Neurologist as a primary care physician-
CLINICA NEUROL, 53: 1148|1148, 2013
Symposium 3
The management of patients receiving home respiratory care with tracheostomy and positive-pressure ventilation
Masashi Aoki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1149|1151, 2013
Symposium 3
Action proposals to Japanese Neurological Society from Fukushima Medical University: based on our three years' experiences
Yoshikazu Ugawa, M.D.1)
CLINICA NEUROL, 53: 1152|1154, 2013
Symposium 3
IT Network establishment for neuropatients
Koji Abe, M.D., P.h.D.1), Shinichiro Uchiyama, M.D.2), Etsuro Matsubara, M.D, Ph.D.3),Shin-ichi Muramatsu, M.D.4), Naoki Atsuta, M.D.5), Kazuo Kitagawa, M.D., Ph.D.6), Yasuyuki Iguchi, M.D., Ph.D.7), Hiroaki Ooboshi, M.D., Ph.D.8), Ryuji Kaji, M.D.9) and Yasuo Terao, M.D., Ph.D.10)
CLINICA NEUROL, 53: 1155|1158, 2013
Symposium 3
Pathophysiology of brain injury and targets of treatment in acute ischemic stroke
Kortaro Tanaka, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1159|1162, 2013
Symposium 3
Intravenous rt-PA therapy: Current status and extending therapeutic time window in Japan
Kazuo Minematsu, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1163|1165, 2013
Symposium 3
Current status of endovascular therapy for acute ischemic stroke
Hiroshi Yamagami, M.D., Ph.D.1) and Nobuyuki Sakai, M.D., D.M.Sc.2)
CLINICA NEUROL, 53: 1166|1168, 2013
Symposium 3
Brain protection against cerebral ischemia
Kazuo Kitagawa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1169|1171, 2013
Symposium 3
Antiplatelet and anticoagulation therapy in acute cerebral infarction
Yoshiaki Itoh, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1172|1174, 2013
Symposium 3
Cell therapy for stroke
Osamu Honmou, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1175|1176, 2013
Symposium 3
Rehabilitation for patients with cerebral infarction after transplantation of autologous human mesenchymal stem cells
Sumio Ishiai, M.D.1)
CLINICA NEUROL, 53: 1177|1179, 2013
Symposium 3
Olfactory mucosa autograft for chronic complete spinal cord injury
Koichi Iwatsuki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1180|1182, 2013
Symposium 3
The basic strategy of rehabilitation for regeneration of spinal cord nerve
Fumihiro Tajima, M.D., Ph.D.1) and Takeshi Nakamura, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1183|1183, 2013
Symposium 3
Rapid identification of meningitis due to bacterial pathogens
Kimiko Ubukata, Ph.D.1)
CLINICA NEUROL, 53: 1184|1186, 2013
Symposium 3
Current advancement of the PCR-based molecular diagnosis for tuberculous meningitis
Teruyuki Takahashi, M.D.1), Masato Tamura, M.D.1)2), Toshiaki Takasu, M.D.1)2) and Satoshi Kamei, M.D.2)
CLINICA NEUROL, 53: 1187|1190, 2013
Symposium 3
Genetic diagnosis against fungal cerebromeningitis
Hideaki Ohno, M.D., Ph.D.1) and Yoshitsugu Miyazaki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1191|1193, 2013
Symposium 3
The diagnosis of toxoplasmic encephalitis by polymerase chain reaction
Takashi Asai, Ph.D.1)
CLINICA NEUROL, 53: 1194|1195, 2013
Symposium 3
History of Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P)
Hiroshi Takashima, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1196|1198, 2013
Symposium 3
Pathomechanisms of motor neuron death by mutant TFG
Toshitaka Kawarai, M.D.1), Mitsuya Morita, M.D.2), Ryoma Morigaki, M.D.3), Koji Fujita, M.D.1), Hiroyuki Nodera, M.D.1), Yuishin Izumi, M.D.1), Satoshi Goto, M.D.3), Imaharu Nakano, M.D.4) and Ryuji Kaji, M.D.1)
CLINICA NEUROL, 53: 1199|1199, 2013
Symposium 3
Neuropathology of proximal-dominant hereditary motor and sensory neuropathy (HMSN-P)
Mari Yoshida, M.D.1)
CLINICA NEUROL, 53: 1200|1202, 2013
Symposium 3
Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) is caused by a mutation in TFG
Hiroyuki Ishiura, M.D. Ph.D.1) and Shoji Tsuji, M.D, Ph.D.1)
CLINICA NEUROL, 53: 1203|1205, 2013
Symposium 3
Muscle ultrasonography: A new diagnostic tool for the diagnosis of ALS
Sonoko Misawa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1206|1207, 2013
Symposium 3
Ultrasonographic diagnosis of demyelinating neuropathy
Takamichi Sugimoto, M.D.1) Kazuhide Ochi, M.D., Ph.D.1) and Masayasu Matsumoto, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1208|1211, 2013
Symposium 3
Ultrasonography of muscle disease
Yuka Terasawa, M.D., Ph.D.1), Naoko Takamatsu, M.T.1) and Ryuji Kaji, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1212|1214, 2013
Symposium 3
Nerve ultrasound is useful for the diagnosis of neuromuscular diseases.
Yu-ichi Noto, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1215|1216, 2013
Symposium 3
Ultrasonography for the management of carpal tunnel syndrome
Kenichi Nakamichi, M.D.1)
CLINICA NEUROL, 53: 1217|1219, 2013
Symposium 4
Pathophysiology of migraine chronification
Mamoru Shibata, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1220|1222, 2013
Symposium 4
Current status of migraine chronification in Japan
Hisanori Kowa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1223|1224, 2013
Symposium 4
Societal impact of migraine chronification
Hisaka Igarashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1225|1227, 2013
Symposium 4
Management of chronic migraine in Japan
Yuka Watanabe, M.D., Ph.D.1), Ryotaro Takashima, M.D., Ph.D.1), Hisatake Iwanami, M.D., Ph.D.1), Shiho Suzuki, M.D., Ph.D.1), Hisaka Igarashi, M.D., Ph.D.2) and Koichi Hirata, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1228|1230, 2013
Symposium 4
Localization in neuropsychology
Kyoko Suzuki, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1231|1233, 2013
Symposium 4
Neural correlates of memory
Toshikatsu Fujii, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1234|1236, 2013
Symposium 4
Aphasia-a new as well as old problem
Kazuo Hadano, M.D.1)
CLINICA NEUROL, 53: 1237|1239, 2013
Symposium 4
Neuropsychology of consciousness
Katsuhiko Takeda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1240|1242, 2013
Symposium 4
Review of basic knowledge, surveillance and infectious control of prion disease
Nobuo Sanjo, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1243|1245, 2013
Symposium 4
Clinical manifestations and epidemiology of prion diseases in Japan.
Tsuyoshi Hamaguchi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1246|1248, 2013
Symposium 4
Neuroimaging in the differential diagnosis of prion disease
Koji Fujita, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1249|1251, 2013
Symposium 4
CSF analysis of patients with prion disease by biomarkers and Real-time qucking-induced conversion (RT-QUIC) method
Katsuya Satoh, M.D.1)
CLINICA NEUROL, 53: 1252|1254, 2013
Symposium 4
Treatment for prion disease: recent progress
Yoshio Tsuboi, M.D.1)
CLINICA NEUROL, 53: 1255|1257, 2013
Symposium 4
Treatment of spasticity with botulinum toxin
Ai Miyashiro, M.D.1)
CLINICA NEUROL, 53: 1258|1260, 2013
Symposium 4
Spasticity must be treated by botulinum toxin with rehabilitaiton
Yoshihisa Masakado, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1261|1263, 2013
Symposium 4
Repetitive transcranial magnetic stimulation and Rehabilitation
Masahiro Abo, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1264|1266, 2013
Symposium 4
Repetitive facilitative exercise: Recent evidence and development for combination therapy
Megumi Shimodozono, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1267|1269, 2013
Symposium 4
Clinical application of prism adaptation for patients with unilateral spatial neglect
Hisaaki Ota, Ph.D.1)
CLINICA NEUROL, 53: 1270|1272, 2013
Symposium 4
Overview of involuntary movements
Yoshikazu Ugawa, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1273|1274, 2013
Symposium 4
Pathophysiology in dystonia: functional anatomy of basal ganglia
Satoshi Goto, M.D.1) and Ryuji Kaji, M.D.2)
CLINICA NEUROL, 53: 1275|1275, 2013
Symposium 4
Pathophysiology of tremor rhythm
Ritsuko Hanajima, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1276|1278, 2013
Symposium 4
Pathophysiology of cortical myoclonus
Tatsuya Mima, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1279|1280, 2013
Symposium 4
Future medical care for intractable diseases, general view
Mieko Ogino, M.D., Ph.D. MMA.1)
CLINICA NEUROL, 53: 1281|1281, 2013
Symposium 4
The prospective program for intractable diseases
Naoko Yamamoto, M.D., M.P.H., Ph.D.1)2)
CLINICA NEUROL, 53: 1282|1282, 2013
Symposium 4
Global strategy for rare and intractable diseases
Tomoko Kawashima Kodama, M.D., M.P.H., Ph.D.1)
CLINICA NEUROL, 53: 1283|1286, 2013
Symposium 4
Medical Treatment of NANBYO from patients' perspective
Tateo Ito1)
CLINICA NEUROL, 53: 1287|1289, 2013
Symposium 4
Comments on the issue and future strategy of policy toward the rare intractable diseases from a standpoint of a neurology specialist
Shigeki Kuzuhara, M.D.1)
CLINICA NEUROL, 53: 1290|1290, 2013
Symposium 4
Management of infectious diseases at home care settings
Kentaro Iwata, M.D.1)
CLINICA NEUROL, 53: 1291|1291, 2013
Symposium 4
Nutritional management in amyotrophic lateral sclerosis: palliative and end-of-life care
Toshio Shimizu, M.D.1)
CLINICA NEUROL, 53: 1292|1294, 2013
Symposium 4
Home care medicine for terminally ill patients
Shohei Kawagoe, M.D.1)
CLINICA NEUROL, 53: 1295|1295, 2013
Symposium 4
To aim at better home medical care
Michiaki Nagura, M.D.1)
CLINICA NEUROL, 53: 1296|1298, 2013
Symposium 4
Clinical factors affecting quality of life and treatment targets in patients with myasthenia gravis
Yuriko Nagane, M.D.1)
CLINICA NEUROL, 53: 1299|1302, 2013
Symposium 4
Treatment of pure ocular myasthenia: a proposal from Japan MG registry 2012
Shigeaki Suzuki, M.D.1)
CLINICA NEUROL, 53: 1303|1305, 2013
Symposium 4
Correlation between oral corticosteroid therapy and present disease status in myasthenia gravis
Tomihiro Imai, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1306|1308, 2013
Symposium 4
Calcineurin inhibitors and IVIg in the treatment of myasthenia gravis
Shunya Nakane, M.D.1)2)
CLINICA NEUROL, 53: 1309|1311, 2013
Symposium 4
A proposal for rituximab treatment in patients with myasthenia gravis
Shingo Konno, M.D.1)
CLINICA NEUROL, 53: 1312|1314, 2013
Symposium 4
Prognostic factors in Guillain-Barré syndrome
Kenichi Kaida, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1315|1318, 2013
Symposium 4
Fisher syndrome and Bickerstaff brainstem encephalitis
Satoshi Kuwabara, M.D.1)
CLINICA NEUROL, 53: 1319|1321, 2013
Symposium 4
A nationwide survey of patients with Bickerstaff brainstem encephalitis: Diversity of underlying mechanism
Michiaki Koga, M.D.1)
CLINICA NEUROL, 53: 1322|1324, 2013
Symposium 4
Autoimmune autonomic ganglionopathy and acute autonomic and sensory neuropathy
Haruki Koike, M.D., Ph.D.1) and Gen Sobue, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1326|1329, 2013
Symposium 4
Overview -exploring molecular basis of sporadic neurologic disorders-
Shoji Tsuji, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1330|1332, 2013
Symposium 4
Chromosomal structural variation -An approach for multiple system atrophy
Ichiro Yabe, M.D., Ph.D.1) and Hidenao Sasaki, M.D, Ph.D.1)
CLINICA NEUROL, 53: 1333|1335, 2013
Symposium 4
Toward identification of susceptible genes for sporadic neurodegenerative disease
Jun Mitsui, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1336|1338, 2013
Symposium 4
Epigenome: what we learned from Rett syndrome, a neurological disease caused by mutation of a methyl-CpG binding protein
Takeo Kubota, M.D.1)
CLINICA NEUROL, 53: 1339|1341, 2013
Symposium 4
Clinical practice guidelines of the Societas Neurologica Japonica
Takeo Nakayama, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1342|1342, 2013
Symposium 4
JSN Treatment Guideline for Parkinson's Disease: its editorial policy and problems to be addressed
Ryosuke Takahashi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1343|1345, 2013
Symposium 4
Treatment & management guidelines 2011 for Parkinson disease
Atsushi Takeda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1346|1347, 2013
Symposium 4
Clinical experiences of the Japanese treatment guideline on Parkinson's disease
Tetsuya Maeda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1348|1350, 2013
Symposium 4
Practice of the Parkinson's disease in the neurology clinic and the role of Guideline
Yoshihisa Tatsuoka, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1351|1351, 2013
Symposium 4
Practical guideline of Parkinson's disease in Japan: evaluation and mission of future
Mitsutoshi Yamamoto, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1352|1353, 2013
Symposium 4
Present status of Japanese neurologists from the questionnaire survey
-to support women doctor's career advancement-
Hikoaki Fukaura, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1354|1357, 2013
Symposium 4
Efforts of gender equality at Kinki University School of Medicine
Katsuichi Miyamoto, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1358|1360, 2013
Symposium 4
Career support systems for female physicians in Tokyo Women's Medical University
Yoriko Kawakami, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1361|1362, 2013
Symposium 4
Advanced approach for gender-equal career enhancement
Yumi Narushima1)
CLINICA NEUROL, 53: 1363|1363, 2013
Symposium 4
Contribution of emergency medicine by neurologists in the western countries: residency training is the key
Hiroyuki Nodera, M.D.1)
CLINICA NEUROL, 53: 1364|1365, 2013
Symposium 4
Immediate stroke life support: Training for neuroresuscitation team in ER
Hiroshi Okudera, M.D., Ph.D.1) and Megumi Takahashi, M.D., Ph.D.2)
CLINICA NEUROL, 53: 1366|1368, 2013
Symposium 4
Significant role of neurologists at ER practice
Hideki Nomura, M.D., Ph.D.1), Chizuko Oishi, M.D.2) and Takeaki Matsuda, M.D., Ph.D.3)
CLINICA NEUROL, 53: 1369|1369, 2013
Symposium 4
Contribution of neurologists to emergent stroke medicine in Japan
Kazunori Toyoda, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1370|1372, 2013
Symposium 4
What ER physicians expects from neurologist
Tomoki Nakamori, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1373|1375, 2013
Symposium 4
The cardiac reserve in Parkinson's disease and exercise therapy
Masaaki Hirayama, M.D.1)2), Tomohiko Nakamura, M.D.2) and Gen Sobue, M.D.2)
CLINICA NEUROL, 53: 1376|1378, 2013
Symposium 4
Impaired exercise-induced blood pressure control in patients with Parkinson's disease and related disorders
Kazushi Deguchi, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1379|1381, 2013
Symposium 4
Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease
Hirokazu Doi, Ph.D.1), Ryuji Sakakibara, M.D. Ph.D.2), Masahiko Kishi, M.D. Ph.D.2), Yohei Tsuyuzaki, M.D.2), Fuyuki Tateno, M.D.2) and Shigekazu Hirai1)
CLINICA NEUROL, 53: 1382|1385, 2013
Symposium 4
Cognitive function and blood pressure regulation in Lewy body diseases
Masato Asahina, M.D, Ph.D.1)
CLINICA NEUROL, 53: 1386|1388, 2013
Symposium 4
Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB
Ryuji Sakakibara, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1389|1392, 2013
Symposium 4
Clinical feature of ALS with communication disturbance; the possibility to communication in TLS
Masahiro Nagao, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1393|1395, 2013
Symposium 4
Predictors the progression of communication impairment in ALS Tracheostomy Ventilator users
Yuki Nakayama, R.N., Ph.D.1), Toshio Shimizu, M.D.2), Kentaro Hayashi, M.D.2), Yoko Mochizuki, M.D., Ph.D.3)4), Masahiro Nagao, M.D., Ph.D.2) and Kiyomitsu Oyanagi, M.D, Ph.D.5)
CLINICA NEUROL, 53: 1396|1398, 2013
Symposium 4
Amyotrophic lateral sclerosis in totally locked-in state
Kiyomitsu Oyanagi, M.D., Ph.D.1), Yoko Mochizuki, M.D., Ph.D.2)3), Yuki Nakayama, R.N., Ph.D.4), Kentaro Hayashi, M.D.5), Toshio Shimizu, M.D.5), Masahiro Nagao, M.D.5), Tomoyo Hashimoto, M.D., Ph.D.1)6), Mineo Yamazaki, M.D., Ph.D.7), Shiro Matsubara, M.D., Ph.D.5) and Takashi Komori, M.D., Ph.D.2)
CLINICA NEUROL, 53: 1399|1401, 2013
Symposium 4
Development of a cognitive BMI "neurocommunicator" as a communication aid of patients with severe motor deficits
Ryohei P. Hasegawa, Ph.D.1)
CLINICA NEUROL, 53: 1402|1404, 2013
Symposium 4
Communication with ALS patients: Neurosurgical approach
Toshiki Yoshimine, M.D., Ph.D.1), Takufumi Yanagisawa, M.D., Ph.D.1), Jin-ichi Sawada, M.D., Ph.D.3), Takanori Hazama, M.D., Ph.D.3), Hideki Mochizuki, M.D., Ph.D.2) and Masayuki Hirata, M.D., Ph.D.1)
CLINICA NEUROL, 53: 1405|1407, 2013